Mayan Gilboa

Also affiliated with Sheba Medical Center, Aventura Hospital and Medical Center

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection”.

Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.31778

N/A

0.744DataRank · unranked

142 citations

Gili Regev-Yochay, Michal Mandelboim, Victoria Indenbaum, Keren Asraf, Ronen Fluss +8 more

Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia—proposal for an umbrella randomized controlled trial

Clinical Microbiology and Infection(2023)10.1016/j.cmi.2023.03.029

N/A

0DataRank · unranked

1 citations

David van Duin, Dafna Yahav, Mayan Gilboa